The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Overview of CHAI’s Vaccines Program
To ensure all children have access to effective and affordable immunization, addressing the main causes of child mortality, CHAI’s Vaccines Markets Team works with vaccine manufacturers, Gavi and other global stakeholders to improve availability, affordability and diversity of supply for existing and future Gavi vaccines. In doing this, CHAI is applying the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment: improving market demand transparency for individual suppliers, and working closely with these suppliers to optimize their commercial, costing and pricing strategies in low and middle income markets, to ensure availability of vaccines, keep prices in these markets affordable, yet commercially sustainable.
As part of this work, CHAI is supporting Gavi and other stakeholders to improve access to vaccines for non-Gavi and former-Gavi middle income countries, through policy as well as supplier and country guidance on vaccine access and procurement. These middle income countries sometimes lag behind lower income countries in introducing new vaccines, as they cannot rely on donor funding and visibility on access conditions for suppliers may be limited.
Close collaboration with CHAI’s country teams and global vaccine delivery team is critical in this area of work.
Since 2011, CHAI has worked in vaccine market shaping and has negotiated price reductions for major vaccines. For example, earlier work has resulted in a reduction in the price of rotavirus vaccine by two-thirds, resulting in savings of over USD$600M for global donors and governments over 5 years and a reduction in the price of pentavalent vaccine by 45%, generating savings of $150M over 4 years.
Some selected news articles about CHAI’s work on access in vaccines and other areas are listed here:
The pandemic context has only reinforced the importance of CHAI’s Vaccines Markets team’s work, coupling the need to ensure supply security for existing vaccines, for which demand and supply dynamics are being disrupted, with the need to accelerate time to market of a suitable COVID-19 vaccine on an unprecedented time frame. CHAI is working closely with many partners towards this goal.
Overview of CHAI South Africa
Over the last few decades, South Africa’s Department of Health (DoH) has made significant progress in increasing access to vaccines in South Africa. However, service delivery challenges still exist. To address these challenges, CHAI South Africa’s (CHAI SA) team is supporting the DoH at national, provincial and district levels to implement a broad range of activities, across demand generation, supply chain strengthening, service delivery expansion, quality improvement and strengthened program monitoring and evaluation, aimed at significantly increasing uptake of quality health services.
The Clinton Health Access Initiative (“CHAI”) strives to be an equal opportunity employer and promotes fairness, respect, equality and dignity in the workplace. CHAI welcomes applications from all qualified individuals and encourages people from historically disadvantaged groups to apply.
The Technical Advisor will be part of the CHAI Vaccines team working to achieve affordable yet sustainable global vaccine prices and supply. The Advisor will report into the South Africa team and work closely with the Global Vaccine Markets and Global Vaccines Delivery teams.
Responsibilities include but are not limited to the following:
South Africa Country team
Global Vaccines Markets team